Journal of Antimicrobial Chemotherapy (1988) 22, 597-604
© 1988 The British Society for Antimicrobial Chemotherapy
research-article |
Distribution of ß-lactamases and phenotype analysis in clinical strains of Acinetobacter calcoaceticus
aDepartment of Microbiology, Bichat University-Hospital 46 Rue Huchard, 75877 Paris Cedex 18 bDepartment of Microbiology, Cochin Hospital Paris, France
Received 16 February 1988; returned 13 July 1988; accepted 13 July 1988
*Corresponding author
One hundred clinical strains of Acinetobacter calcoaceticus isolated from 1981 to 1986 were screened for enzymatic resistance to ß-lactam antibiotics. Fourteen ß-antibiotics were tested and four phenotypes were defined on the basis of enzymatic resistance and of susceptibility to the following ß-lactams: ticarcillin, piperacillin, cefotaxime, and ceftazidime. The resistance of A. calcoaceticus to ß-lactam antibiotics was predominantly due to ß-lactamases, which were produced by 81% of the strains. In most (71%) of the ß-lactamase producing strains, a penicillinase of the TEM type was observed; in 9% of the strains, all isolated since 1985, a CARB-type penicillinase with a pI 6·3 was observed. The presence of a cephalosporinase type enzyme was detected in acinetobacter strains isolated since 1981 and its incidence increased in 1986. Multiple ß-lactamases (penicillinase plus cephalosporinase) were observed in 32% of the strains.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. C. Papagiannitsis, A. Loli, L. S. Tzouvelekis, E. Tzelepi, G. Arlet, and V. Miriagou SCO-1, a Novel Plasmid-Mediated Class A {beta}-Lactamase with Carbenicillinase Characteristics from Escherichia coli Antimicrob. Agents Chemother., June 1, 2007; 51(6): 2185 - 2188. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Fernandez-Cuenca, L. Martinez-Martinez, M{a} C. Conejo, J. A. Ayala, E. J. Perea, and A. Pascual Relationship between {beta}-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii J. Antimicrob. Chemother., March 1, 2003; 51(3): 565 - 574. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Danes, M. M. Navia, J. Ruiz, F. Marco, A. Jurado, M. T. Jimenez de Anta, and J. Vila Distribution of {beta}-lactamases in Acinetobacter baumannii clinical isolates and the effect of Syn 2190 (AmpC inhibitor) on the MICs of different {beta}-lactam antibiotics J. Antimicrob. Chemother., August 1, 2002; 50(2): 261 - 264. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Bou, G. Cerveró, M. A. Domínguez, C. Quereda, and J. Martínez-Beltrán Characterization of a Nosocomial Outbreak Caused by a Multiresistant Acinetobacter baumannii Strain with a Carbapenem-Hydrolyzing Enzyme: High-Level Carbapenem Resistance in A. baumannii Is Not Due Solely to the Presence of beta -Lactamases J. Clin. Microbiol., September 1, 2000; 38(9): 3299 - 3305. [Abstract] [Full Text] |
||||
![]() |
G. Bou, A. Oliver, and J. Martínez-Beltrán OXA-24, a Novel Class D beta -Lactamase with Carbapenemase Activity in an Acinetobacter baumannii Clinical Strain Antimicrob. Agents Chemother., June 1, 2000; 44(6): 1556 - 1561. [Abstract] [Full Text] |
||||
![]() |
L. Poirel, M. Guibert, S. Bellais, T. Naas, and P. Nordmann Integron- and Carbenicillinase-Mediated Reduced Susceptibility to Amoxicillin-Clavulanic Acid in Isolates of Multidrug-Resistant Salmonella enterica Serotype Typhimurium DT104 from French Patients Antimicrob. Agents Chemother., May 1, 1999; 43(5): 1098 - 1104. [Abstract] [Full Text] |
||||
![]() |
M. Afzal-Shah, H. E. Villar, and D. M. Livermore Biochemical characteristics of a carbapenemase from an Acinetobacter baumannii isolate collected in Buenos Aires, Argentina J. Antimicrob. Chemother., January 1, 1999; 43(1): 127 - 131. [Abstract] [Full Text] [PDF] |
||||


